---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-119270"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:38:48.960436+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MiNK appoints former HHS ASPR Robert Kadlec to board

## Summary
- Dr. Robert Kadlec elected Class II director effective Oct. 30, 2024; term expires at 2026 annual meeting.
- Previously served as HHS Assistant Secretary for Preparedness and Response and co-conceived Operation Warp Speed.
- Will serve on Corporate Governance and Nominating Committee; granted option for 41,745 shares vesting over 3 years.
- Expertise in biodefense and pandemic preparedness aligns with MiNK's iNKT cell therapy focus on ARDS and infectious diseases.

## SEC filing metadata
- accession: 0000950170-24-119270
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000095017024119270/0000950170-24-119270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000095017024119270/inkt-20241030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-119270
- JSON: https://secwatch.observer/filing/0000950170-24-119270.json
- Plain text: https://secwatch.observer/filing/0000950170-24-119270.txt

## Key facts
- Executive change
  Robert Kadlec was elected as Director at MiNK Therapeutics, Inc..
  - Action: elected
  - Role: Director
  source text: On October 30, 2024, the Board of Directors (the “Board”) of MiNK Therapeutics Inc., ("MiNK") elected Dr. Robert Kadlec to become a Class II director of MiNK with an initial term that expires at MiNK's annual meeting of stockholders in 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840229/000095017024119270/0000950170-24-119270-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.